HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
BSX holding history
Boston Scientific Corp in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BSX overviewAll 13F holders of BSXFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,495
- Value
- $319.9K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,495 | $319.9K | <0.1% | +225+3.1% | Added | Holders |
| Q1 2026 | 7,270 | $456.2K | <0.1% | +378+5.5% | Added | Holders |
| Q4 2025 | 6,892 | $657.2K | <0.1% | +198+3.0% | Added | Holders |
| Q3 2025 | 6,694 | $653.5K | <0.1% | −181−2.6% | Reduced | Holders |
| Q2 2025 | 6,875 | $738.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 6,875 | $693.5K | <0.1% | +98+1.4% | Added | Holders |
| Q4 2024 | 6,777 | $605.3K | <0.1% | −6−0.1% | Reduced | Holders |
| Q3 2024 | 6,783 | $568.4K | <0.1% | +30+0.4% | Added | Holders |
| Q2 2024 | 6,753 | $520.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6,753 | $462.5K | <0.1% | +83+1.2% | Added | Holders |
| Q4 2023 | 6,670 | $385.6K | <0.1% | −936−12.3% | Reduced | Holders |
| Q3 2023 | 7,606 | $401.6K | <0.1% | +2,236+41.6% | Added | Holders |
| Q2 2023 | 5,370 | $290.5K | <0.1% | −150−2.7% | Reduced | Holders |
| Q1 2023 | 5,520 | $276.2K | <0.1% | +4,286+347.3% | Added | Holders |
| Q4 2022 | 1,234 | $57.1K | <0.1% | −55−4.3% | Reduced | Holders |
| Q3 2022 | 1,289 | $50.0K | <0.1% | +88+7.3% | Added | Holders |
| Q2 2022 | 1,201 | $45.0K | <0.1% | −32−2.6% | Reduced | Holders |
| Q1 2022 | 1,233 | $55.0K | <0.1% | +33+2.8% | Added | Holders |
| Q4 2021 | 1,200 | $51.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,200 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,200 | $51.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,200 | $46.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.